Evidence map›Paper›PMID 33978321›Full record

ArticleGenes, brain, and behavior2022

Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome model.

Kayla R Nygaard, Raylynn G Swift, Rebecca M Glick, Rachael E Wagner, Susan E Maloney, Georgianna G Gould, Joseph D Dougherty

Abstract read
In one paragraph

Article in Genes, brain, and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Extensive characterization of a Williams Syndrome murine model showsbioRxiv : the preprint server for biology · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kayla R NygaardDepartment of Genetics, Washington University in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0003-1640-3026
Raylynn G SwiftDepartment of Genetics, Washington University in St. Louis, St. Louis, Missouri, USA.
Rebecca M GlickDepartment of Genetics, Washington University in St. Louis, St. Louis, Missouri, USA.
Rachael E WagnerDepartment of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.
Susan E MaloneyDepartment of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0001-5585-4722
Georgianna G GouldDepartment of Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, Texas, USA.
Joseph D DoughertyDepartment of Genetics, Washington University in St. Louis, St. Louis, Missouri, USA.

Funding

WUIDDRC Supplement-Supporting the health and well-being of children with intellectual and developmental disability during COVID-19 pandemicP50HD103525 · NICHD · WASHINGTON UNIVERSITY · PI JOSEPH D DOUGHERTY, Natasha Marrus · 2020 to 2026
$15.5M
REGULATION OF MAMMALIAN SOCIAL BEHAVIOR BY THE GTF2I FAMILY OF PROTEINSR01MH107515 · NIMH · WASHINGTON UNIVERSITY · PI DOUGHERTY, JOSEPH D · 2016 to 2020
$2.4M
National Institute of Child Health and Human Development P50HD103525NICHD NIH HHS P50 HD103525NIMH NIH HHS R01 MH107515
6 · The paper itself

Abstract

Williams Syndrome results in distinct behavioral phenotypes, which include learning deficits, anxiety, increased phobias and hypersociability. While the underlying mechanisms driving this subset of phenotypes is unknown, oxytocin (OT) dysregulation is hypothesized to be involved as some studies have shown elevated blood OT and altered OT receptor expression in patients. A "Complete Deletion" (CD) mouse, modeling the hemizygous deletion in Williams Syndrome, recapitulates many of the phenotypes present in humans. These CD mice also exhibit impaired fear responses in the conditioned fear task. Here, we address whether OT dysregulation is responsible for this impaired associative fear memory response. We show direct delivery of an OT receptor antagonist to the central nervous system did not rescue the attenuated contextual or cued fear memory responses in CD mice. Thus, increased OT signaling is not acutely responsible for this phenotype. We also evaluated OT receptor and serotonin transporter availability in regions related to fear learning, memory and sociability using autoradiography in wild type and CD mice. While no differences withstood correction, we identified regions that may warrant further investigation. There was a nonsignificant decrease in OT receptor expression in the lateral septal nucleus and nonsignificant lowered serotonin transporter availability in the striatum and orbitofrontal cortex. Together, these data suggest the fear conditioning anomalies in the Williams Syndrome mouse model are independent of any alterations in the oxytocinergic system caused by deletion of the Williams locus.

Indexed as

FearMemoryAnimalsBrainFemaleMaleMiceReceptors, OxytocinSocial BehaviorWilliams SyndromeReceptors, Oxytocinassociative fearautoradiographybehavioral geneticsconditioned fearmouse modelOXTRoxytocinoxytocin receptor antagonistSERTWilliams Syndrome

Identifiers

PMID33978321
PMCPMC8842878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.